U.S. Physical Therapy, Inc. (NYSE:USPH) Shares Sold by Riverbridge Partners LLC

Riverbridge Partners LLC trimmed its position in U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 7.7% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 310,210 shares of the company's stock after selling 25,921 shares during the period. Riverbridge Partners LLC owned approximately 2.05% of U.S. Physical Therapy worth $27,519,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Canada Pension Plan Investment Board purchased a new stake in shares of U.S. Physical Therapy during the 2nd quarter worth $28,000. Quarry LP boosted its position in shares of U.S. Physical Therapy by 1,291.9% in the 2nd quarter. Quarry LP now owns 515 shares of the company's stock worth $48,000 after buying an additional 478 shares in the last quarter. KBC Group NV boosted its position in shares of U.S. Physical Therapy by 68.6% in the 3rd quarter. KBC Group NV now owns 774 shares of the company's stock worth $66,000 after buying an additional 315 shares in the last quarter. Benjamin F. Edwards & Company Inc. boosted its position in shares of U.S. Physical Therapy by 74.5% in the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 958 shares of the company's stock worth $89,000 after buying an additional 409 shares in the last quarter. Finally, First Horizon Advisors Inc. boosted its position in shares of U.S. Physical Therapy by 25.1% in the 3rd quarter. First Horizon Advisors Inc. now owns 1,486 shares of the company's stock worth $126,000 after buying an additional 298 shares in the last quarter.

U.S. Physical Therapy Trading Up 0.8 %

Shares of NYSE USPH traded up $0.76 on Thursday, reaching $91.03. 44,045 shares of the company traded hands, compared to its average volume of 78,662. U.S. Physical Therapy, Inc. has a fifty-two week low of $76.18 and a fifty-two week high of $113.63. The company has a 50 day moving average of $92.48 and a 200 day moving average of $88.86. The company has a current ratio of 1.78, a quick ratio of 1.78 and a debt-to-equity ratio of 0.27. The stock has a market capitalization of $1.37 billion, a PE ratio of 96.84, a P/E/G ratio of 3.71 and a beta of 1.48.

U.S. Physical Therapy Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, December 6th. Stockholders of record on Friday, November 15th were issued a dividend of $0.44 per share. This represents a $1.76 dividend on an annualized basis and a dividend yield of 1.93%. The ex-dividend date of this dividend was Friday, November 15th. U.S. Physical Therapy's payout ratio is currently 187.23%.

Insider Transactions at U.S. Physical Therapy

In other U.S. Physical Therapy news, COO Graham D. Reeve sold 1,724 shares of the stock in a transaction that occurred on Friday, November 8th. The shares were sold at an average price of $96.29, for a total value of $166,003.96. Following the completion of the sale, the chief operating officer now owns 7,106 shares of the company's stock, valued at $684,236.74. This trade represents a 19.52 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Nancy Ham sold 1,172 shares of the stock in a transaction that occurred on Friday, November 8th. The shares were sold at an average price of $96.72, for a total transaction of $113,355.84. Following the completion of the sale, the director now directly owns 1,112 shares of the company's stock, valued at $107,552.64. This trade represents a 51.31 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 7,412 shares of company stock worth $706,605. 1.70% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on USPH shares. Bank of America upgraded shares of U.S. Physical Therapy from a "neutral" rating to a "buy" rating and boosted their price objective for the stock from $100.00 to $115.00 in a research report on Monday, December 16th. Barrington Research reissued an "outperform" rating and issued a $108.00 target price on shares of U.S. Physical Therapy in a research note on Thursday, November 21st. JMP Securities assumed coverage on shares of U.S. Physical Therapy in a research note on Monday, December 16th. They issued an "outperform" rating and a $113.00 target price for the company. JPMorgan Chase & Co. boosted their target price on shares of U.S. Physical Therapy from $117.00 to $120.00 and gave the company an "overweight" rating in a research note on Tuesday, December 3rd. Finally, Citizens Jmp raised shares of U.S. Physical Therapy to a "strong-buy" rating in a research note on Monday, December 16th. One analyst has rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, U.S. Physical Therapy has an average rating of "Buy" and a consensus target price of $114.00.

U.S. Physical Therapy Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.